Peptides.info

Ghrelin-receptor / GH secretagogue

GHRP-6

Clinical

The unnatural peptide that led researchers to ghrelin.

Cited sources
3
Human-tested claims
2 of 3
Best evidence
Tier 2 · Clinical
Status
Research-only

The original growth-hormone-releasing peptide, a synthetic hexapeptide designed in the 1980s before anyone knew what receptor it hit. The hunt for that receptor produced ghrelin. It releases GH in people by every route tested, raises cortisol as well, and was never developed as a drug.

GH-axissecretagogueinvestigational

How it works

GHRP-6 is a ghrelin-receptor (GHS-R1a) agonist. It was built by trial and error from enkephalin fragments; its receptor was cloned in 1996 and the natural ligand, ghrelin, was found in 1999. It stimulates GH directly at the pituitary and through the hypothalamus, and in people it also stimulates ACTH and cortisol and provokes hunger.

Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂A hexapeptide with two D-amino acids, so no one-letter form applies.

What it's studied for

One claim per card, each with its own tier and source. Tiers 1 and 2 are human data. Tiers 3 and 4 are not yet.

Safety & limitations

In healthy men it raised ACTH and cortisol overnight alongside GH, the opposite of GHRH, which blunts cortisol. That is the clearest difference from ipamorelin, and the reason 'selective' secretagogues were developed.

[1]Frieboes et al., 1995 (Neuroendocrinology)(opens in a new tab)

No long-term human safety data exist. The hunger-promoting effect of ghrelin-receptor agonists is well documented and is a feature, not a side effect, of the mechanism.

[3]Bowers, 2001 (J Clin Endocrinol Metab review)(opens in a new tab)

Regulatory & legal status

Research-only

Never approved in any jurisdiction. A research tool with a short human-study record in the 1990s, now sold in grey markets.

[3]Bowers, 2001 (J Clin Endocrinol Metab review)(opens in a new tab)

Frequently asked

How does GHRP-6 differ from ipamorelin?

Same receptor, different selectivity. GHRP-6 raises cortisol and prolactin along with GH in human studies; ipamorelin was engineered to avoid that, at least in preclinical work. GHRP-6 is also the stronger appetite stimulant.

References

Written by Twenty Residues editorial. Medical review: pending; a named reviewer is being assigned.

Last updated October 1, 2026.

Spot an error or a better source? Report a correction. Every change is logged below.

Update history
  • 2026-10-01 — Entry added.